Contact Us

Location:Frontiers logo
Frontiers Administration is located in the Fairway North building on the Fairway Campus of the University of Kansas Medical Center:

Mail Stop 7003
4330 Shawnee Mission Parkway, Suite 3320
Fairway, Kansas 66205

Mailing List:
Get the latest updates on Frontiers events, news, funding opportunities, and more - sign up for our newsletter.

Administration Team: 

Vice Chancellor for Research
Gertrude and Dewey Ziegler Professor
University Distinguished Professor and Chairman, Department of Neurology, 
University of Kansas Medical Center

Barohn headshotDr. Richard Barohn is a graduate of the University of Missouri-Kansas City School of Medicine. He completed a neurology residency at Wilford Hall United States Air Force Medical Center and then completed a neuromuscular fellowship at Ohio State University.

Dr. Barohn is board certified in adult neurology by the American Board of Psychiatry and Neurology with added qualifications in clinical neurophysiology and neuromuscular medicine. He is also certified by the American Board of Electrodiagnostic Medicine.

Dr. Barohn holds membership in many professional societies, including the American Academy of Neurology (fellow status), the American Neurological Association, and the Association of University Professors of Neurology. Dr. Barohn has served on the national medical advisory boards for the Myasthenia Gravis Foundation and the Guillain-Barre Syndrome Foundation International and The Myositis Association. He was the recipient of the 2000 Alumni Achievement Award for Medicine from the University of Missouri-Kansas City and of the University of Kansas Chancellor’s Club Research Award in 2012. In 2013 he was designated a University Distinguished Professor by the University of Kansas.

His present research focuses on myopathies (such as polymyositis and muscular dystrophy), motor neuron disease (such as amyotrophic lateral sclerosis), peripheral neuropathies, and myasthenia gravis. He was the lead principal investigator of the multi-center study of mexiletine in nondystrophic myotonia that was recently published in JAMA.  Dr. Barohn is the author of more than 200 journal publications and over 50 book chapters on various aspects of neuromuscular disease. He is the Principal Investigator on the NIH Clinical and Translational Science Award and the NeuroNEXT grant at KU Medical Center. He is the Director of Frontiers: The Heartland Institute for Clinical and Translational Research. He has served on the editorial board for Neurology and is the Associate Editor for the Journal of Clinical Neuromuscular Disorders. He was the Founding Chair of the Section of Neuromuscular Disease in the American Academy of Neurology.

Associate Director William Brooks

Associate Director Kim Kimminau

Administrative Officer Jennifer Maddox

Research Communications Coordinator Michelle Strausbaugh

Administrative Assistant Gi Anni Hicks